{"code":"E11.5","type":"code","title":"Type 2 diabetes mellitus with circulatory complications","codeAlso":[],"includes":["diabetes (mellitus) due to insulin secretory defect","diabetes NOS","insulin resistant diabetes (mellitus)"],"modern_v":"official26","codeFirst":[],"excludes1":["diabetes mellitus due to underlying condition (E08.-)","drug or chemical induced diabetes mellitus (E09.-)","gestational diabetes (O24.4-)","neonatal diabetes mellitus (P70.2)","postpancreatectomy diabetes mellitus (E13.-)","postprocedural diabetes mellitus (E13.-)","secondary diabetes mellitus NEC (E13.-)","type 1 diabetes mellitus (E10.-)"],"excludes2":[],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":false,"billableFy2027":false},"sibling_codes":["E11.51","E11.52","E11.59"],"inclusionTerms":[],"sibling_titles":{"code":"E11.59","title":"Type 2 diabetes mellitus with other circulatory complications","isBillable":true},"useAdditionalCode":["code to identify control using:","injectable non-insulin antidiabetic drugs (Z79.85)","insulin (Z79.4)","oral antidiabetic drugs (Z79.84)","oral hypoglycemic drugs (Z79.84)"],"clinicalDefinition":"Type 2 diabetes mellitus with circulatory complications is a non-billable ICD-10-CM category code (E11.5). A more specific billable subcode must be selected for claims submission. Includes: diabetes (mellitus) due to insulin secretory defect; diabetes NOS; insulin resistant diabetes (mellitus). Excludes1 (not coded here): diabetes mellitus due to underlying condition (E08.-); drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.","officialDefinition":"Type 2 diabetes mellitus with circulatory complications is a non-billable ICD-10-CM category code (E11.5). A more specific billable subcode must be selected for claims submission. Includes: diabetes (mellitus) due to insulin secretory defect; diabetes NOS; insulin resistant diabetes (mellitus). Excludes1 (not coded here): diabetes mellitus due to underlying condition (E08.-); drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); postpancreatectomy diabetes mellitus (E13.-); postprocedural diabetes mellitus (E13.-); secondary diabetes mellitus NEC (E13.-); type 1 diabetes mellitus (E10.-). Use additional code: code to identify control using:; injectable non-insulin antidiabetic drugs (Z79.85); insulin (Z79.4); oral antidiabetic drugs (Z79.84); oral hypoglycemic drugs (Z79.84).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}